Results 1 to 10 of about 92,350 (272)

The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation

open access: yesOpen Access Rheumatology: Research and Reviews, 2012
Shatara V Townes,1 Daniel E Furst,1 Anuradha Thenkondar21Department of Rheumatology, University of California-Los Angeles, Los Angeles, CA, USA; 2Sri Ramachandra Medical College and Research Institute, Chennai, IndiaObjective: To determine the impact of ...
Townes SV, Furst DE, Thenkondar A
doaj   +1 more source

Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India: a retrospective cohort study [PDF]

open access: yesAcute and Critical Care
Background Itolizumab downregulates the synthesis of proinflammatory cytokines and adhesion molecules by inhibiting CD6 leading to lower levels of interferon-γ, interleukin-6, and tumor necrotic factor-α and reduced T-cell infiltration at inflammatory ...
Abhyuday Kumar   +6 more
doaj   +1 more source

Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis

open access: yesCase Reports in Rheumatology, 2012
Tocilizumab, a humanized anti-human interleukin-6 (IL-6) receptor monoclonal antibody, is beneficial for treating autoimmune conditions such as rheumatoid arthritis (RA).
Asumi Tada   +3 more
doaj   +1 more source

The effect of tocilizumab administration on inflammatory markers in COVID-19 patients

open access: yesThe Egyptian Journal of Bronchology
Background The COVID-19 outbreak was declared a worldwide emergency as a result of its rapid spread. The number of people infected with COVID-19 is increasing rapidly around the world, and pneumonia can develop in COVID-19 cases.
Engy Mohamed Riyad Soliman   +3 more
doaj   +1 more source

The efficacy and safety of tocilizumab in juvenile localised scleroderma patients: a retrospective cohort study in Eastern China

open access: yesAdvances in Rheumatology
Background Localised scleroderma is a rare autoimmune connective tissue disorder characterized by excessive collagen deposition leading to skin fibrosis.
Yang Shen   +9 more
doaj   +1 more source

An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

open access: yesFrontiers in Pharmacology
BackgroundIn the context of the cytokine storm the takes place in severe COVID-19 patients, the Interleukin 6 (IL6) pathway emerges as one of the key pathways involved in the pathogenesis of this hyperinflammatory state.
Alejandro Durán-Sotuela   +7 more
doaj   +1 more source

Use of 18F‐fluorodeoxyglucose Positron Emission Tomography to Monitor Disease Activity in Patients With Giant Cell Arteritis on Tocilizumab

open access: yesACR Open Rheumatology
Objective The objective of this study was to assess the value of 18F‐fluorodeoxyglucose (FDG)– positron emission tomography (PET) scans to monitor disease activity in patients with giant cell arteritis (GCA) on tocilizumab. Methods Patients with GCA were
Kaitlin A. Quinn   +2 more
doaj   +1 more source

High Mortality Rate in Severe COVID-19 Despite Tocilizumab Administration: A Case Series

open access: yesJKS (Jurnal Kedokteran Syiah Kuala)
Introduction: Tocilizumab is a potential therapeutic agent for modulating cytokine storms, a known cause of multiorgan failure and mortality in severe COVID-19.
Cokorda Agung Wahyu Purnamasidhi   +4 more
doaj   +1 more source

Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection – Case Series Report

open access: yesInfection and Drug Resistance
Chunlan Fu,1 Yuanyuan Zhu,2 Weijia Huang,2 Yi Luo,2 Yongxian Hu,2 He Huang,2 Jie Sun2 1Department of Hematology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, Zhejiang, 311800, People’s Republic of China; 2Transplantation Center, The ...
Fu C   +6 more
doaj  

Home - About - Disclaimer - Privacy